TrialEuropean journal of drug metabolism and pharmacokinetics2020

Safety, Tolerability and Pharmacokinetics of Vidofludimus calcium (IMU-838) After Single and Multiple Ascending Oral Doses in Healthy Male Subjects.

Andreas Muehler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.